Treatment for recurrent hepatitis C

Minerva Chirurgica

Volumn 58, Issue 5, 2003, Pages 693-703

  Ghobrial, R M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antiviral agents; Hepatitis C, therapy; Liver transplantation; Recurrence; Retransplantation

Indexed keywords

ALPHA INTERFERON; HEPATITIS C ANTIBODY; INOSINATE DEHYDROGENASE INHIBITOR; LEVOVIRIN; RIBAMIDINE; RIBAVIRIN; UNCLASSIFIED DRUG;

ALLOGRAFT; BLEEDING; BONE MARROW SUPPRESSION; BRAIN DISEASE; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; FLU LIKE SYNDROME; GRAFT FAILURE; HEMOLYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERSPLENISM; LIVER TRANSPLANTATION; NEUTROPENIA; PATIENT SELECTION; RECURRENT INFECTION; REOPERATION; REVIEW; SEPSIS; SIDE EFFECT; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT PLANNING; WEIGHT REDUCTION;

ANTIVIRAL AGENTS; HEPATITIS C; HUMANS; LIVER TRANSPLANTATION; PROGNOSIS; RECURRENCE; REOPERATION; SURVIVAL RATE; TIME FACTORS;

EID: 0346336887     PISSN: 00264733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Teixeira R, Pastacaldi S, Papatheodoridis GV, Burroughs AK. Recurrent hepatitis C after liver transplantation. J Med Virol 2000;61:443-54.
2. Charlton M, Scaberg E, Wiesner R, Everhart J, Zettenman R, Lake J et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998;28:823-30.
3. Ghobrial RM, Farmer DG, Baquerizo A, Colquhoun S, Rosen H, Yersiz H et al. Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression and causes of retransplantation during an eight year single center experience. Ann Surg 1999;6:824-33.
4. Casavilla FA, Rakela J, Kapur S, Irish W, McMichael J, Demetris AJ et al. Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under Tacrolimus. Liver Transplant Surg 1998;4:448-54.
5. Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996;334:815-20.
6. Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992;103:317-22.
7. Ghobrial RM, Steadman R, Gornbein J, Lassman C, Holt H, Chen P et al. A ten year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg 2000;232:312-23.
8. Rosen H, Gretch DR, Oehlke M, Flora KD, Benner KG, Rabkin JM et al. Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury. Transplantation 1998;65:1178-82.
9. Samuel D, Feray C. Recurrent hepatitis C after liver transplantation: clinical and therapeutic issues. J Viral Hepat 2000;7:87-92.
10. Feray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF et al. The course of hepatitis C virus infection after liver transplantation. Hepatology 1994;20:1137-43.
11. Zhou S, Terrault NA, Ferrell L, Hahn JA, Lau JY, Simmonds P et al. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology 1996;24:1041-6.
12. Sreekumar S, Gonzalez-Koch A, Maor-Kendler Y, Batts KP, Moreno-Luna L, Poterucha J et al. Early identification of recipients with progressive histological recurrence of hepatitis C after liver transplantation. Hepatology 2000;32:1125-30.
13. Prieto M, Berenguer M, Rayon JM, Cordoba J, Arguello L, Carrasco D et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology 1999;29:250-6.
14. Feray C, Caccamo L, Alexander GJ, Ducot B, Gugenheim J, Casanovas T et al. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology 1999;117:619-25.
15. Sheiner PA, Schluger LK, Emre S, Thung SN, Lau JYN, Guy SR et al. Retransplantation for hepatitis C. Liver Transpl Surg 1997;3:130-6.
16. Rosen HR, O'Reilly PM, Shackleton CR, McDiarmid S, Holt C, Busuttil RW et al. Graft loss following liver transplantation in patients with chronic hepatitis C. Transplantation 1996;62:1773-6.
17. Doyle HR, Morelli F, McMichael J, Doria C, Aldrighetti L, Starzl TE et al. Hepatic retransplantation - an analysis of risk factors associated with outcome. Transplantation 1996;61:1499-505.
18. Markmann JF, Markowitz JS, Yersiz H, Morrisey M, Farmer DG, Farmer DA et al. Long-term survival after retransplantation of the liver. Ann Surg 1997;226:408-20.
19. Schluger LK, Sheiner PA, Thung SN, Lau JY, Min A, Wolf DC et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 1996;23:971-6.
20. Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV et al. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Am J Gastroenterol 1997;92:1453-7.
21. Testa G, Crippin JS, Netto GJ, Goldstein RM, Jennings LW, Brkic BS et al. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients. Liver Transpl 2000;6:553-61.
22. Berenguer M, Prieto M, San Juan F, Rayon JM, Martinez M, Carrasco D et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002;36:202-10.
23. Ghobrial R, Huang Y, Farmer D, Carmody I, Gornbein J, Steadman R et al. Postransplant hepatitis recurrence is influenced by non-viral transplant related factors: ten-year analysis in over 300 patients. Am J Transpl 2003;3 Suppl 5:519.
24. Trotter J, Schiano T, Wachs M, Kim-Schluger L, Bak T, Kugelmas M et al. Living donor liver transplantation [abstract] in hepatitis C patients: short-term results compared to cadaveric transplantation [abstract]. Am J Transpl 2001;1S:316A.
25. Grobial RM, Amersi F, Farmer DG, Chen P, Anselmo DM, Baquerizo A, et al. Rapid and severe early HCV recurrence following adult living donor liver transplantation Am J Transpl 2002;2 Suppl 3:300.
26. Charlton M. Pre-emptive treatment of recurrent hepatitis C infection. Liver Transpl 2002;8:S50-4.
27. Gane E. Treatment of recurrent hepatitis C. Liver Transpl 2002;8:S28-37.
28. Zdilar D, Franco-Bronson K, Buchler N, Locala JA, Younossi ZM. Hepatitis C, interferon alfa and depression. Hepatology 2000;31:1207-11.
29. Magnone M, Holley J, Shapiro R, Scantlebury V, McCauley J, Jordan M et al. Interferon-alpha-induced acute renal allograft rejection. Transplantation 1995;59:1068-70.
30. Jain A, Demetris A, Manez R, Tsamadas A, Van Thiel D, Rakela J et al. Incidence and severity of acute allograft rejection in liver transplant recipients treated with alpha interferon. Liver Transpl Surg 1998;4:197-203.
31. Szabo G, Katz E, Bonkovsky HL. Management of recurrent hepatitis C after liver transplantation: a concise review. Am J Gastroenterol 2002;95:2164-70.
32. Gane E, Lo SK, Portmann BC, Riordan SM, Lau JYN, Naoumov NV et al. A randomized study comparing ribavirin and interferon-alpha monotherapy for hepatitis C recurrence after liver transplantation. Hepatology 1998;27:1403-7.
33. Wright HGL, Van Thiel D. Preliminary experience with alpha2-b interferon therapy of viral hepatitis in liver allograft recipients. Transplantation 1992;53:121-4.
34. Feray C, Samuel D, Gigou M, Paradis V, Reynes M, Bismuth H. An open trial of interferon-a recombinant for hepatitis C after liver transplantation. Hepatology 1995;22:1084-9.
35. Cotler S, Ganger D, Kaur S, Rosenblate H, Jakate S, Sullivan D et al. Daily interferon for HCV infection in liver transplant recipients. Transplantation 2001;71:261-6.
36. Bizzollon T, Palazzo U, Ducerf C, Chevallier M, Elliot M, Pouyer M et al. Pilot study of combination of interferon alpha and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology 1997;26:500-4.
37. Bellati G, Alberti A, Belli L, Vai C, Airoldi A, Rondinara G et al. Therapy of chronic hepatitis C after liver transplantation: multicenter Italian experience [abstract]. J Hepatol 1999;30 Suppl 1:51.
38. Zamboni F, Franchello A, Lavezzo B, Strignano P, Schellino M, Rizzetto M et al. Treatment of recurrent hepatitis C after liver transplantation with interferon alpha 2b and ribavirin [abstract]. J Hepatol 2000;32 Suppl 1:265.
39. Ahmad J, Dodson S, Demetris A, Fung J, Shakil A. Recurrent hepatitis C after liver transplantation: a non-randomized trial of interferon alfa alone versus interferon alfa plus ribavirin. Liver Transpl 2001;7:863-9.
40. Gopal D, Rapkin J, Berk B, Corless C, Chott S, Olyaei A. Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin. Liver Transpl 2001;7:181-90.
41. Alberti A, Belli L, Airoldi A, DeCarlis L, Rondinara S, Minola E et al. Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study. Liver Transpl 2001;7:870-6.
42. Samuel D, Bizollon T, Feray C, Ahmed S, Cohard M, Bismuth H et al. Combination interferon alpha and ribavirin for recurrent HCV infection after liver transplantation: a randomized controlled study [abstract]. Hepatology 2000;32:542A.
43. Crippin J, McCashand T, Terrault T, Sheiner P, Charlton M. A pilot study for the tolerability and efficacy of anti-viral therapy in hepatitis C-infected patients awaiting liver transplantation. Liver Transpl 2002;4:350-5.
44. Sheiner P, Boros P, Klion FM, Thung S, Schugler L, Lau J et al. The efficacy of prophylactic interferon alfa-eb in preventing recurrent hepatitis C after liver transplantation. Hepatology 1998;28:831-8.
45. Singh N, Gayowski T, Wannstedt CF, Shakil O, Wagner MM, Fung J et al. Interferon-α for prophylaxis of recurrent viral hepatitis C in liver transplantation. Transplantation 1998;65:82-6.
46. Mazzalerro V, Tagger A, Schiavo M, Regalia E, Pulvirenti A, Ribero M et al. Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment. Transpl Proceed 2001;33:1355-7.
47. Bizzolon T, Ahmed S, Radenne S, Chevallier M, Chevallier P, Parvaz P et al. Long-term histologic improvement and clearance of intrahepatic HCV RNA following sustained response to IFN-ribavirin combination therapy in liver transplanted patients with HCV recurrence. Gut 2003;52:283-7.
48. Willems B, Ede M, Marotta P, Greig P, Lilly L, Kneteman N et al. Anti-HCV immunoglobulins for the prevention of graft infection in HCV-related liver transplantation. J Hepatol 2002;36 Suppl 1:S96A.
49. Andreone P, Gramenzi A, Cursaro C, Biselli M, Di Giammarino L, Grazi G et al. Interferon plus ribavirin and amantadine in patients with posttransplant hepatitis C: results of a pilot study. Dig Liver Dis 2001;33:6937.
50. Haig P, Mullerova I, Tang K, Proto S, Chokshi S, Williams R et al. Analysis of the immunomodulatory activity of levovirin, a second generation ribavirin analogue, on T cell responses. J Hepatol 2002;36 Suppl 1:S24.
51. Ghobrial RM. Retransplantation for recurrent hepatitis C. Liver Transpl 2002;8:S38-43.
52. Rosen HR. Retransplantation for hepatitis C: implications of different policies. Liver Transpl 2000;6:S41-6.
53. Rosen H, Martin P. Hepatitis C infection in patients undergoing liver retransplantation. Transplantation 1998;66:1612-6.
54. Facciuto M, Heidt D, Guarrera J, Bodian CA, Miller CM, Emre S et al. Retransplantation for late liver graft failure: predictors of mortality. Liver Transpl 2000;6:174-9.
55. Sheiner PA. Hepatitis C after liver transplantation. Semin Liver Dis 2000;20:201-9.